title: Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl.
abstract: BACKGROUND
  Primary hyperparathyroidism (PHPT) is usually associated with hypercalcemia and inappropriately elevated serum PTH.
  
  
  OBJECTIVE
  Our objective was to identify the reason(s) for a low serum intact PTH in a child with PHPT.
  
  
  METHODS
  A 14-yr-old Caucasian girl presented with pancreatitis, nephrolithiasis, hypercalcemia ranging from 13.2 to 17.5 mg/dl, and a low serum intact PTH. She had an ultrasound and technetium-99m-sestamibi scintigraphy confirming the presence of a parathyroid adenoma.
  
  
  RESULTS
  The preoperative serum intact PTH assays performed at Quest Diagnostics, Nichols Institute, were low even after serial dilutions, whereas the intraoperative turbo PTH assay was elevated at 3618 pg/ml. C-terminal and cyclase-activating PTH assays for PTH were also elevated. PTH gene sequence analysis performed from DNA extracted both from the parathyroid adenoma and the patient's peripheral blood leukocytes was negative for a mutation in the PTH gene sequence.
  
  
  CONCLUSIONS
  The contrasting values on the intact PTH assay and the turbo PTH assay suggest that the adenoma was producing an aberrant PTH molecule that was not detected by the routine intact PTH assay. Because there was no change in PTH gene sequence, this could be indicative of a posttranslational change in the PTH molecule that would not be recognized solely by DNA sequencing. Therefore, a low or normal PTH measurement against the backdrop of clinical and biochemical hyperparathyroidism needs measurement with a variety of assays.
authors: Department of Pediatrics/Division of Pediatric Endocrinology and Metabolism, Children's Hospital, University of Alabama at Birmingham, Birmingham, Alabama 35233, USA.
authors: Amanda D
authors: AD
authors: Benaderet
authors: Amy M
authors: AM
authors: Burton
authors: Roderick
authors: R
authors: Clifton-Bligh
authors: Ambika P
authors: AP
authors: Ashraf
references: J Clin Endocrinol Metab. 1994 Jan;78(1):107-13
references: 7904610
references: Clin Chem. 2005 May;51(5):915-7
references: 15855672
references: Am J Med. 1991 Nov;91(5):547-8
references: 1951417
references: Clin Endocrinol (Oxf). 2008 Sep;69(3):382-5
references: 18284640
references: N Engl J Med. 2008 Sep 11;359(11):1184-6
references: 18784115
references: Clin Endocrinol (Oxf). 1998 Apr;48(4):435-43
references: 9640410
references: Endocr Rev. 2005 Feb;26(1):78-113
references: 15689574
references: N Engl J Med. 1988 Mar 17;318(11):658-62
references: 3344017
references: J Clin Endocrinol Metab. 2007 Jan;92(1):277-83
references: 17018660
references: QJM. 2000 Jun;93(6):365-7
references: 10873186
references: Clin Chem. 2007 Aug;53(8):1470-6
references: 17599957
references: QJM. 1996 Dec;89(12):921-32
references: 9015486
references: J Clin Endocrinol Metab. 2006 Oct;91(10):3826-9
references: 16849415
references: World J Surg Oncol. 2008 Feb 21;6:24
references: 18291038
references: Med J Aust. 1996 Aug 19;165(4):197-8
references: 8773648
references: Laryngoscope. 2007 May;117(5):946-9
references: 17473702
references: Pediatrics. 2005 Apr;115(4):974-80
references: 15805373